![Jay Luly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Luly
Amministratore Delegato presso
ENANTA PHARMACEUTICALS, INC.
Patrimonio netto: 11 M $ in data 31/05/2026
Profilo
Jay R.
Luly is President, Chief Executive Officer & Director at Enanta Pharmaceuticals, Inc. since 2003.
Former positions include Director at Artesian Therapeutics, Inc., Senior Vice President-Drug Discovery & Pre-Clinical Development at Abbott Laboratories from 1983 to 1997, Senior Vice President-Research & Development Operations at Millennium Pharmaceuticals, Inc., Senior Vice President-Drug Discovery & Preclinical Development at LeukoSite, Inc., and Trustee at The Boston Biomedical Research Institute.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/02/2026 | 871.871 ( 3% ) | 11 M $ | 31/05/2026 |
Posizioni attive di Jay Luly
| Società | Posizione | Inizio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Amministratore Delegato | 01/07/2003 |
Precedenti posizioni note di Jay Luly
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direttore Tecnico/Scientifico/R&S | - |
The Boston Biomedical Research Institute | Direttore/Membro del Consiglio | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Direttore/Membro del Consiglio | - |
Formazione di Jay Luly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Boston Biomedical Research Institute |
